Getting to Know GU

from Dr. Chris Wallis

Intensifying Treatment in mCSPC - Part 1

On this episode, guest speakers Dr. Maria Jiang & Dr. Andrew Loblaw join our host to share their thoughts on the latest in the rapidly changing treatment landscape of advanced prostate cancer. 
 
Learning Objectives: 
  • Review new treatment options, including triplet therapy 
  • Discuss MDT Patient Management: Who to refer and when? 
Speaker Disclosures: (Honoraria, Consulting or Advisory Role, Research Funding) 
 
Dr. Maria Jiang: Amgen, AstraZeneca, Bayer, EMD Serono, Ipsen, Janssen Oncology, Merck, McKesson, Pfizer, TerSera 
Dr. Andrew Loblaw: AbbVie, Astellas, Bayer, Janssen, Knight, Sanofi, TerSera, Tolmar 
 
Disclaimer: 
“Getting to Know GU” is a Podcast, (Other Learning Activity) sponsored by Bayer Inc., intended for Healthcare Professionals interested and/or working in Urology & GU Oncology. Full editorial control of this program’s content resides with the speaker(s).​ Statements of fact and opinions expressed are those of the speaker(s) and do not necessarily reflect the opinions or position of Bayer Inc. ​ 
  
In accordance with the Innovative Medicines Canada Code of Ethical Practices, this program is limited to Healthcare Professionals.

PP-PF-ONC-CA-0046-1
View more episodes »